These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6678878)

  • 1. Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group study.
    Smith FE; Gad-el-Mawla N; Tranum B; Baker LH; Panettiere FJ; Athens JW; Foulkes M
    Invest New Drugs; 1983; 1(4):315-9. PubMed ID: 6678878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase II trial of rubidazone and adriamycin in women with advanced breast cancer.
    Ingle JN; Ahmann DL; O'Fallon JR; Bisel HF; Rubin J; Kvols LK; Giuliani ER
    Cancer Treat Rep; 1979; 63(11-12):1701-5. PubMed ID: 526908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies with rubidazone.
    Benjamin RS; Keating MJ; Swenerton KD; Legha S; McCredie KB
    Cancer Treat Rep; 1979 May; 63(5):925-9. PubMed ID: 287557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubidazone in the treatment of recurrent acute leukemia in children. A Pediatric Oncology Group Study.
    Ragab AH; Boyett JM; Frankel L; Falletta J
    Cancer; 1986 Apr; 57(8):1461-3. PubMed ID: 3948126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
    Fraile RJ; Samson MK; Buroker TR; O'Bryan R; Baker LH; Vaitkevicius VK
    Cancer Treat Rep; 1978 Oct; 62(10):1599-601. PubMed ID: 361229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer.
    Martoni A; Pacciarini MA; Pannuti F
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):803-6. PubMed ID: 3862582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study.
    Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K
    Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idarubicin in advanced breast cancer: a phase II study.
    Lionetto R; Pronzato P; Conte PF; Sertoli MR; Amoroso D; Rosso R
    Cancer Treat Rep; 1986 Dec; 70(12):1439-40. PubMed ID: 3466694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumors.
    Kovach JS; Ames MM; Sternad ML; O'Connell MJ
    Cancer Res; 1979 Mar; 39(3):823-8. PubMed ID: 427770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial with oral idarubicin in advanced breast cancer.
    Lopez M; Di Lauro L; Papaldo P; Lazzaro B; Ganzina F; Di Pietro N
    Invest New Drugs; 1986; 4(1):39-42. PubMed ID: 3457780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of rubidazone (NSC 164011) in children with cancer.
    Tan CT; Mitta SK; Steinherz L; Miller DR
    Med Pediatr Oncol; 1981; 9(4):347-53. PubMed ID: 7266427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
    Stuart NS; Cullen MH; Priestman TJ; Blackledge GR; Tyrrell CJ
    Cancer Chemother Pharmacol; 1988; 21(4):351-4. PubMed ID: 3163529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of rubidazone in solid tumors and malignant lymphomas.
    Skovsgaard T; Hansen HH; Mouridsen HT; Nissen NI; Pedersen-Bjergaard J
    Cancer Treat Rep; 1978 Jul; 62(7):1053-8. PubMed ID: 356967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group Study.
    Zidar BL; Benjamin RS; Frank J; Lane M; Baker LH
    Am J Clin Oncol; 1983 Feb; 6(1):71-4. PubMed ID: 6837508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephroma.
    Scher HI; Yagoda A; Ahmed T; Budman D; Sordillo P; Watson RC
    Cancer Chemother Pharmacol; 1985; 14(1):79-80. PubMed ID: 3855289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of menogaril in patients with advanced cancer.
    Brown TD; Donehower RC; Grochow LB; Rice AP; Ettinger DS
    J Clin Oncol; 1987 Jan; 5(1):92-9. PubMed ID: 2949065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients.
    Bastholt L; Dalmark M
    Cancer Treat Rep; 1987 May; 71(5):451-4. PubMed ID: 3471329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of 4-demethoxydaunorubicin in patients with advanced malignant melanoma.
    Stanton G; Casper ES; Friedman B
    Cancer Treat Rep; 1985; 69(7-8):915-6. PubMed ID: 3860298
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology Group.
    Knight WA; Von Hoff DD; Neidhart JA; Tranum BL; Fabian C; Jones SE
    Invest New Drugs; 1983; 1(2):181-4. PubMed ID: 6678866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
    Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
    J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.